In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-alpha and ribavirin combination.
about
Antiviral perspectives for chikungunya virusInhibition of Chikungunya Virus Replication by 1-[(2-Methylbenzimidazol-1-yl) Methyl]-2-Oxo-Indolin-3-ylidene] Amino] Thiourea(MBZM-N-IBT)The Chikungunya Epidemic: A look at five casesCritical role for bone marrow stromal antigen 2 in acute Chikungunya virus infection.Development of Neutralization Assay Using an eGFP Chikungunya VirusChikungunya vaccines in developmentN-methylisatin-beta-thiosemicarbazone derivative (SCH 16) is an inhibitor of Japanese encephalitis virus infection in vitro and in vivoEstablishment of one-step SYBR green-based real time-PCR assay for rapid detection and quantification of chikungunya virus infectionChikungunya Virus Infection: An Update on Joint Manifestations and ManagementMutagenic Effects of Ribavirin on Hepatitis E Virus-Viral Extinction versus Selection of Fitness-Enhancing MutationsMosquito-transmitted viruses - the great Brazilian challengeIdentification of novel compounds inhibiting chikungunya virus-induced cell death by high throughput screening of a kinase inhibitor libraryInduction Effect to Apoptosis by Maitake Polysaccharide: Synergistic Effect of Its Combination With Vitamin C in Neuroglioma Cell.Hyper-production and characterization of the ι-carrageenase useful for ι-carrageenan oligosaccharide production from a deep-sea bacterium, Microbulbifer thermotolerans JAMB-A94T, and insight into the unusual catalytic mechanism.Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays.A phenotypic assay to identify Chikungunya virus inhibitors targeting the nonstructural protein nsP2.The Effect of Aqueous Extract of Glycyrrhiza glabra on Herpes Simplex Virus 1.Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expressionRetrospective survey of Chikungunya disease in Réunion Island hospital staff.Characterization of synthetic Chikungunya viruses based on the consensus sequence of recent E1-226V isolatesHigh-content image-based screening of a signal transduction pathway inhibitor small-molecule library against highly pathogenic RNA viruses.Kinetic characterization of trans-proteolytic activity of Chikungunya virus capsid protease and development of a FRET-based HTS assay.Molecular Modeling and Docking Study to Elucidate Novel Chikungunya Virus nsP2 Protease InhibitorsAntiviral Phosphorodiamidate Morpholino Oligomers are Protective against Chikungunya Virus Infection on Cell-based and Murine ModelsReemergence of Chikungunya virus in Indian Subcontinent.Hepatoprotective Activity of Licorice Water Extract against Cadmium-induced Toxicity in RatsPolyanionic drugs and viral oncogenesis: a novel approach to control infection, tumor-associated inflammation and angiogenesis.Approaches to the treatment of disease induced by chikungunya virus.Emerging alphaviruses in the Americas: Chikungunya and Mayaro.Chikungunya virus: recent advances in epidemiology, host pathogen interaction and vaccine strategies.Synergistic Apoptotic Effect of D-Fraction From Grifola frondosa and Vitamin C on Hepatocellular Carcinoma SMMC-7721 Cells.Identification of Nucleoside Analogs as Inducers of Neuronal Differentiation in a Human Reporter Cell Line and Adult Stem Cells.Development of a Real-Time Cell Analysing (RTCA) method as a fast and accurate screen for the selection of chikungunya virus replication inhibitorsChikungunya Virus.Inhibition of vaccinia virus replication by two small interfering RNAs targeting B1R and G7L genes and their synergistic combination with cidofovir.Evaluation of cell viability dyes in antiviral assays with RNA viruses that exhibit different cytopathogenic properties.Discovery of a Broad-Spectrum Antiviral Compound That Inhibits Pyrimidine Biosynthesis and Establishes a Type 1 Interferon-Independent Antiviral State.Chikungunya infection in a human immunodeficiency virus-infected kidney transplant recipient returning to Italy from the Dominican Republic.Protocols for Developing Novel Chikungunya Virus DNA Vaccines.Antiviral Strategies Against Chikungunya Virus.
P2860
Q21284682-1B3BA015-11AF-4769-83BB-599EC518F5EEQ24289284-28A418C8-8374-43A5-847D-5BEAD2D7BB8EQ24701725-E7E31EAE-916D-4288-8AEA-FC1930A78ABAQ24701738-E325D18B-63E3-4F22-9CEA-1065F19C87BBQ26314416-0EE511B5-2486-4524-AB72-A33F7EF17C8BQ26700081-AF9DD000-AD59-4109-B2C8-FBD8FBC2D120Q27486224-6317CBB2-AFC8-42F7-91FB-3483881BE82AQ27490969-471F9467-B13A-4D3F-940F-91BE25CDC7FEQ27928037-84311219-F49E-408B-98F4-CD4AF8A26676Q28072953-BB841086-F514-4859-9A18-C678C50EC559Q28078140-3B9457A9-8A34-4485-BC30-021C6D7A5ECDQ28534763-87C6ABF6-5D53-4BE8-9590-93FDD0562CFCQ32176956-B2101412-3747-4E33-A513-C8B73E0791DCQ33649912-81E42151-8FC1-4DB0-A69C-67E631BC9952Q34113650-D9CBEA97-CBA1-4FE7-8376-ECE00FFC53E4Q34415623-225BCBF8-0301-46FF-9414-54F4F57EBF6AQ34437502-C14A24AC-C605-45EB-BB62-AACFC877A1FFQ34527618-4A03A386-2B68-40A5-AAFF-DD9D901E20A2Q34618922-F58DC907-BDBD-45E1-BCA9-2E61C11948EDQ34926408-3B6E3ED7-3C1E-4CC2-B592-A16591B46011Q35363438-B98CFB01-A4AF-482A-B495-F80C09F465CAQ35800438-B6111553-E9C0-4A7B-A469-F7DD5C0746B6Q36291814-74B5C4FE-E58C-4EAB-9B79-141495D37CCFQ36292209-675E3F4E-1AC7-4B51-BC6E-0165315028F3Q36550117-0760AABA-06AA-43B4-A778-48D3D59BD61CQ37202868-63827DD3-9991-4E1D-98CB-85983FFC7C22Q37323266-9F2BCF90-0D48-4D1E-BAF8-7C3DD5E065C3Q37592380-C33B5670-A27B-44CB-BB94-7A4CD719FCB6Q38334478-9419BFD4-258F-4453-BB68-EE2222E77EE2Q38666344-9601EED2-11EE-4243-A516-66937029C0DDQ38772866-D5DC67EF-743C-4412-96F9-98A349984858Q38936117-4107989D-72B2-45E4-954A-B908E05C906EQ39216330-4CFDB72D-5AFF-4105-B4C8-BB1E5D5D4813Q39273197-60004464-599C-4114-B869-A684F7AA0B83Q39869286-083D0F60-F8BF-460C-9482-601AB62BE80EQ40063157-1F2EDB1F-06D4-4138-B7E9-9F79A1C55C01Q40105589-2177B6FB-559A-4289-A8F2-8CDEB18BFDF5Q40122582-D90431D3-4EB4-4D33-97EC-3C6A6FA37513Q40656550-864148BB-C568-4A78-8E1C-EEE3A0EAE3ECQ40656579-6B59F4C9-29EE-4DD9-B3CD-7B12A56099F4
P2860
In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-alpha and ribavirin combination.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
In vitro inhibition of Chikung ...... pha and ribavirin combination.
@ast
In vitro inhibition of Chikung ...... pha and ribavirin combination.
@en
type
label
In vitro inhibition of Chikung ...... pha and ribavirin combination.
@ast
In vitro inhibition of Chikung ...... pha and ribavirin combination.
@en
prefLabel
In vitro inhibition of Chikung ...... pha and ribavirin combination.
@ast
In vitro inhibition of Chikung ...... pha and ribavirin combination.
@en
P2093
P921
P1433
P1476
In vitro inhibition of Chikung ...... pha and ribavirin combination.
@en
P2093
P304
P356
10.1016/J.ANTIVIRAL.2003.09.005
P5008
P577
2004-02-01T00:00:00Z